Viemed sets October 20 event while Viemed Healthcare stock trades below EUR 8.38

Published on 10/08/2026 at 14:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue was USD 78.10 million in 2026's second quarter, up 24.00 percent. Viemed Healthcare stock costs EUR 8.30 on October 8, 2026 versus EUR 8.38.

VMD, CA92663R1055, Illustration mit AI erstellt.

Viemed Healthcare (CA92663R1055) was at EUR 8.30 at Lang & Schwarz on October 8, 2026 at 2:32 p.m. CEST, versus a EUR 8.38 prior close. On October 6, 2026, the company announced an October 20, 2026 presentation at the LD Micro Main Event, where CEO Casey Hoyt and management will appear, according to Yahoo Finance.

Three events shaped the year

On November 6, 2025, Viemed held its third-quarter 2025 earnings call; on August 3, 2026, second-quarter revenue reached USD 78.10 million; and on October 6, 2026, the company announced its October 20 presentation. The second-quarter figure was 24.00 percent above the prior-year quarter, according to Viemed Healthcare.

What does the event mean for growth?

The presentation comes after a quarter in which Viemed reported USD 2.90 million of net income, diluted earnings per share of USD 0.07 and operating cash flow of USD 15.90 million. The company also raised the low end of its full-year 2026 revenue guidance to USD 314 million from USD 312 million, while keeping the upper end at USD 320 million, according to Viemed Healthcare.

That growth has come with a margin trade-off. Adjusted EBITDA was USD 13.70 million, or a 17.60 percent margin, in the second quarter, compared with 22.70 percent in the prior-year quarter; management attributed the comparison partly to a prior-year non-recurring equipment disposal gain, according to Yahoo Finance.

Next dates and stock context

Viemed's next dated investor event is the October 20, 2026 presentation, followed by the October 21, 2026 closing day of the LD Micro Main Event, according to Yahoo Finance. The company also disclosed on September 24, 2026, that President Michael Moore adopted an automatic disposition plan covering up to 246,000 shares, with sales potentially beginning December 24, 2026, according to National Law Review.

Stock stays below the prior close

At Lang & Schwarz, Viemed stock was EUR 8.30 on October 8, 2026 at 2:32 p.m. CEST, down 0.95 percent versus the EUR 8.38 prior close of October 7, 2026. On Nasdaq, the stock was last at USD 9.37 on October 7, 2026 at 4:00 p.m. ET, with a 52-week range of USD 6.05 to USD 12.61 and market capitalization of USD 356.9 million. The further course of trading is shown by the continuously updated real-time quote of Viemed Healthcare stock.